Janet Rehnquist - Dec 28, 2023 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Janet Rehnquist
Stock symbol
NRXP
Transactions as of
Dec 28, 2023
Transactions value $
$0
Form type
3
Date filed
1/16/2024, 06:36 PM

No securities are beneficially owned.